Page last updated: 2024-11-04

sk&f 97541 and Seizures

sk&f 97541 has been researched along with Seizures in 1 studies

3-aminopropyl(methyl)phosphinic acid: structure given in first source; GABA-A receptor antagonist

Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.

Research Excerpts

ExcerptRelevanceReference
"It suppressed tonic phase of generalized seizures induced by pentetrazol in 7-, 12- and 18-day-old rats and increased their latency in 7- and 12-day-old animals."1.35Anticonvulsant action of GABA-B receptor agonist SKF97541 differs from that of baclofen. ( Mares, P, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mares, P1

Other Studies

1 other study available for sk&f 97541 and Seizures

ArticleYear
Anticonvulsant action of GABA-B receptor agonist SKF97541 differs from that of baclofen.
    Physiological research, 2008, Volume: 57, Issue:5

    Topics: Age Factors; Animals; Anticonvulsants; Baclofen; Disease Models, Animal; Dose-Response Relationship,

2008